Le Lézard
Classified in: Health
Subjects: CHI, SVY, EXE, WOM

More birth defects seen in parts of U.S. with local Zika spread


ATLANTA, Jan. 25, 2018 /PRNewswire-USNewswire/ -- Birth defects most strongly linked to Zika virus infection during pregnancy have increased in parts of the United States that have had local Zika virus transmission, according to a report in CDC's Morbidity and Mortality Weekly Report (MMWR). Areas with local transmission of Zika ? southern Florida, a portion of south Texas, and Puerto Rico ? saw a 21 percent increase in births with outcomes most strongly linked to Zika virus in the last half of 2016 compared with births in the first half of that year.

Centers For Disease Control And Prevention (PRNewsFoto/CDC) (PRNewsFoto/CDC)

It is not known if this increase is due to local transmission of Zika virus alone, or if there are other contributing factors. Most of the mothers who had babies with the Zika virus-linked birth defects did not have laboratory evidence of Zika virus infection?either because they were not tested, were not tested at the right time, or were not exposed to Zika virus. All cases with birth defects potentially related to Zika virus infection are monitored by birth defects surveillance systems.

"Babies with Zika-related birth defects need all the help they can get, as soon as possible and for as long as they need it," said CDC Director Brenda Fitzgerald, M.D. "This report highlights the critical importance of documenting birth defects possibly related to Zika and our need to maintain vigilance."

CDC looked at nearly 1 million births in 2016 in 15 U.S. states and territories, including Florida (select southern counties), Georgia (select metro-Atlanta counties), Hawaii, Iowa, Illinois, Massachusetts, New Jersey, New York (excluding New York City), North Carolina (select regions), Puerto Rico, Rhode Island, South Carolina, Texas (select regions), Utah, and Vermont.

About three out of every 1,000 babies born in 15 states and territories in 2016 had a birth defect possibly associated with Zika virus infection in the mother:

Because many pregnant women exposed to Zika virus in late 2016 gave birth in 2017, CDC researchers anticipate that there could be another increase in possible Zika-related birth defects when 2017 data are analyzed.

CDC uses tracking systems to find birth defects that might be related to Zika virus:

"Our pregnancy and birth defects surveillance networks are a collaborative effort with state, local, and territorial health departments and are essential to protect mothers and babies affected by Zika virus," said Peggy Honein, Ph.D., M.P.H., acting director, Division of Congenital and Developmental Disorders,  National Center on Birth Defects and Developmental Disabilities. "These networks can also be used as models to help track other known and emerging health threats for mothers and babies."

For more information about Zika virus and pregnancy visit www.cdc.gov/pregnancy/zika.

US Department of Health and Human Services

CDC works 24/7 protecting America's health, safety and security. Whether disease start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America's most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.

Contact: CDC Media Relations
(404) 639-3286

SOURCE Centers for Disease Control and Prevention (CDC)


These press releases may also interest you

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...



News published on and distributed by: